Treace Medical Concepts, Inc. Business Combination, Acquisition Related Costs
Treace Medical Concepts, Inc. (TMCI) reported Business Combination, Acquisition Related Costs of $0 for the 3-month period ending 2025-12-31, per its DEF 14A filed 2026-04-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2026-04-06
- Treace Medical Concepts, Inc. business combination, acquisition related costs for the quarter ending 2025-12-31 was $0.00.
- Treace Medical Concepts, Inc. business combination, acquisition related costs for the quarter ending 2024-12-31 was $0.00.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|
| 2025-12-31 | $0.00 DEF 14A · filed 2026-04-06 | $0.00 DEF 14A · filed 2026-04-06 |
| 2024-12-31 | $0.00 DEF 14A · filed 2026-04-06 | $1.87M DEF 14A · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |